Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
暂无分享,去创建一个
M. Paesmans | T. Berghmans | F. Branle | F. Lemaître | C. Mascaux | A. Meert | J. Sculier | E. Rubesova | P. Vermylen | F. Lemaitre